September 5, 2026
Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal




The Phase 3 study found a drug didnโ€™t reduce the risk of cardiovascular events like heart attacks and strokes.

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *